Ausgabe 11/2023
Inhalt (9 Artikel)
Conducting Trial-Based Economic Evaluations Using R: A Tutorial
Ângela Jornada Ben, Johanna M. van Dongen, Mohamed El Alili, Jonas L. Esser, Hana Marie Broulíková, Judith E. Bosmans
Cost-Effectiveness of Emerging Treatments for Atopic Dermatitis: A Systematic Review
Katja C. Heinz, Charlotte Beaudart, Damon Willems, Isabell Wiethoff, Mickaël Hiligsmann
Systematic Literature Review to Identify Cost and Resource Use Data in Patients with Early-Stage Non-small Cell Lung Cancer (NSCLC)
Nick Jovanoski, Seye Abogunrin, Danilo Di Maio, Rossella Belleli, Pollyanna Hudson, Sneha Bhadti, Libby G. Jones
Economic and Humanistic Burden of Osteoarthritis: An Updated Systematic Review of Large Sample Studies
Xuejing Jin, Wanxian Liang, Lining Zhang, Shihuan Cao, Lujia Yang, Feng Xie
A Systematic Review of Cost-Effectiveness Studies of Newer Non-Insulin Antidiabetic Drugs: Trends in Decision-Analytical Models for Modelling of Type 2 Diabetes Mellitus
Henrik Vitus Bering Laursen, Emmelie Ploug Jørgensen, Peter Vestergaard, Lars Holger Ehlers
EQ-5D-5L Value Set for Slovenia
Valentina Prevolnik Rupel, Marko Ogorevc
Development and Validation of txSim: A Model of Advanced Lung Cancer Treatment in Australia
Preston Ngo, Deme Karikios, David Goldsbury, Stephen Wade, Zarnie Lwin, Brett G. M. Hughes, Kwun M. Fong, Karen Canfell, Marianne Weber
Vaccinating the German Population Aged 60 Years and Over with a Quadrivalent High-Dose Inactivated Influenza Vaccine Compared to Standard-Dose Vaccines: A Transmission and Budget Impact Model
Kathrin Pahmeier, Christian Speckemeier, Silke Neusser, Jürgen Wasem, Janine Biermann-Stallwitz
Correction: Belimumab for Treating Active Autoantibody‑Positive Systemic Lupus Erythematosus: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
Thomas Otten, Rob Riemsma, Ben Wijnen, Nigel Armstrong, Lisa Stirk, Caroline Gordon, Bram Ramaekers, Jos Kleijnen, Manuela Joore, Sabine Grimm